TScan Therapeutics, Inc. Common Stock (NASDAQ: TCRX) last traded at $0.779, up 0.43% on the session. The quote above updates while this page is open; the figures below are drawn from TScan Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
TScan Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TCRX. Its market capitalisation is $101.30 million.
Valuation measures for TScan Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $101.30M |
|---|---|
| Enterprise value | $103.57M |
| Price / sales | 14.24 |
| Price / book | 1.47 |
| Beta | 1.54 |
Trailing-twelve-month figures tagged in TScan Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $7.11M |
|---|---|
| Net income (TTM) | -$117.71M |
| EPS (TTM) | -$0.910 |
| Operating margin | -1695.15% |
| Return on equity | -170.55% |
| Cash | $100.16M |
Range and volume for TCRX over the past 52 weeks.
| 52-week high | $2.57 |
|---|---|
| 52-week low | $0.716 |
| Volume | 136.1K |
| Average volume | 612.4K |
| Previous close | $0.776 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.